Cerebrospinal fluid sTREM2 and PGRN in the early diagnosis and progression monitoring of Alzheimer's disease: A longitudinal study

Background Alzheimer's disease (AD) features amyloid-β (Aβ) deposition and tau pathology, with microglial dysfunction and neuroinflammation increasingly implicated. Soluble triggering receptor expressed on myeloid cells-2 (sTREM2) and progranulin (PGRN) regulate microglial function and lysosomal homeostasis, but their dynamics across the AD continuum remain unclear. Objective To investigate cerebrospinal fluid (CSF) sTREM2 and PGRN in the early diagnosis and progression monitoring of AD, and their associations with Aβ pathology and other biomarkers. Methods Data were from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Based on CSF Aβ 42 and Clinical Dementia Rating (CDR) scores, subjects were categorized into Aβ−CN (n = 196), Aβ+CN (n = 101), Aβ+MCI (n = 378), and Aβ+AD (n = 96). Baseline demographics, neuropsychological assessments, imaging indices, and CSF biomarkers were compared. Spearman correlation, ROC curve analysis, and linear mixed-effects models (n = 255) were used. Results Baseline CSF sTREM2 was lower in Aβ+CN than Aβ−CN. PGRN was lower in Aβ+CN and Aβ+MCI than Aβ−CN. Over 2 years, sTREM2 increased most in Aβ+MCI and moderately in Aβ+CN, while PGRN declined in Aβ−CN, Aβ+MCI, and Aβ+AD. Both biomarkers correlated with CSF tau and p-tau in Aβ+ individuals. Conclusions Baseline CSF sTREM2 and PGRN have limited cross-sectional diagnostic value for AD. However, their longitudinal trajectories raise the possibility that they may reflect the microglia-lysosome axis. Combined biomarker strategies and multi-targeted therapeutic interventions warrant further investigation.

Authors

Institutions

Publication Details

Journal
Journal of Alzheimer s Disease
Published
2026-11-18
DOI
https://doi.org/10.1177/13872877261507326
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cerebrospinal fluid sTREM2 and PGRN in the early diagnosis and progression monitoring of Alzheimer's disease: A longitudinal study

Kemeng Bai, Xiaofeng Li, Xifen Gong, for the Alzheimer’s Disease Neuroimaging Initiative et al.
1 links
Journal of Alzheimer s Disease
Alzheimer's disease research and treatments
article

Cerebrospinal fluid sTREM2 and PGRN in the early diagnosis and progression monitoring of Alzheimer's disease: A longitudinal study

Kemeng Bai, Xiaofeng Li, Xifen Gong, for the Alzheimer’s Disease Neuroimaging Initiative, Ziqi Zhou, Jiayu Li, Jinyun Long, Muhammad Uzair Khalid
article en

Abstract

Background Alzheimer's disease (AD) features amyloid-β (Aβ) deposition and tau pathology, with microglial dysfunction and neuroinflammation increasingly implicated. Soluble triggering receptor expressed on myeloid cells-2 (sTREM2) and progranulin (PGRN) regulate microglial function and lysosomal homeostasis, but their dynamics across the AD continuum remain unclear. Objective To investigate cerebrospinal fluid (CSF) sTREM2 and PGRN in the early diagnosis and progression monitoring of AD, and their associations with Aβ pathology and other biomarkers. Methods Data were from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Based on CSF Aβ 42 and Clinical Dementia Rating (CDR) scores, subjects were categorized into Aβ−CN (n = 196), Aβ+CN (n = 101), Aβ+MCI (n = 378), and Aβ+AD (n = 96). Baseline demographics, neuropsychological assessments, imaging indices, and CSF biomarkers were compared. Spearman correlation, ROC curve analysis, and linear mixed-effects models (n = 255) were used. Results Baseline CSF sTREM2 was lower in Aβ+CN than Aβ−CN. PGRN was lower in Aβ+CN and Aβ+MCI than Aβ−CN. Over 2 years, sTREM2 increased most in Aβ+MCI and moderately in Aβ+CN, while PGRN declined in Aβ−CN, Aβ+MCI, and Aβ+AD. Both biomarkers correlated with CSF tau and p-tau in Aβ+ individuals. Conclusions Baseline CSF sTREM2 and PGRN have limited cross-sectional diagnostic value for AD. However, their longitudinal trajectories raise the possibility that they may reflect the microglia-lysosome axis. Combined biomarker strategies and multi-targeted therapeutic interventions warrant further investigation.

Journal of Alzheimer s Disease
Second Affiliated Hospital of Chongqing Medical University (CN)
Good health and well-being
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon